{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:27:57Z","timestamp":1780579677171,"version":"3.54.1"},"reference-count":10,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2021,8,24]]},"DOI":"10.1001\/jama.2021.12481","type":"journal-article","created":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T16:09:54Z","timestamp":1627920594000},"page":"697","source":"Crossref","is-referenced-by-count":58,"title":["Two Models of Legalization of Psychedelic Substances"],"prefix":"10.1001","volume":"326","author":[{"given":"William R.","family":"Smith","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia"},{"name":"Scattergood Program for Applied Ethics of Behavioral Health Care, Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul S.","family":"Appelbaum","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, New York, New York"},{"name":"Center for Law, Ethics and Psychiatry, New York State Psychiatric Institute, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"5","key":"jvp210090r1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1176\/appi.ajp.2019.19010035","article-title":"Psychedelics and psychedelic-assisted psychotherapy.","volume":"177","author":"Reiff","year":"2020","journal-title":"Am J Psychiatry"},{"issue":"15","key":"jvp210090r2","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of psilocybin versus escitalopram for depression.","volume":"384","author":"Carhart-Harris","year":"2021","journal-title":"N Engl J Med"},{"issue":"6","key":"jvp210090r3","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/s41591-021-01336-3","article-title":"MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.","volume":"27","author":"Mitchell","year":"2021","journal-title":"Nat Med"},{"issue":"2","key":"jvp210090r4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/15563650.2020.1784914","article-title":"MDMA-related presentations to the emergency departments of the European Drug Emergencies Network plus (Euro-DEN Plus) over the four-year period 2014-2017.","volume":"59","author":"Noseda","year":"2021","journal-title":"Clin Toxicol (Phila)"},{"issue":"12","key":"jvp210090r5","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1177\/0269881116662634","article-title":"Survey study of challenging experiences after ingesting psilocybin mushrooms.","volume":"30","author":"Carbonaro","year":"2016","journal-title":"J Psychopharmacol"},{"issue":"3","key":"jvp210090r6","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1177\/0269881114565653","article-title":"Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population.","volume":"29","author":"Hendricks","year":"2015","journal-title":"J Psychopharmacol"},{"issue":"8","key":"jvp210090r7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063972","article-title":"Psychedelics and mental health.","volume":"8","author":"Krebs","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"jvp210090r8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/jamapsychiatry.2019.3254","article-title":"Association between recreational marijuana legalization in the United States and changes in marijuana use and cannabis use disorder from 2008 to 2016.","volume":"77","author":"Cerd\u00e1","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"jvp210090r9","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.copsyc.2021.03.005","article-title":"Trends over time in adult cannabis use.","volume":"38","author":"Hasin","year":"2021","journal-title":"Curr Opin Psychol"},{"issue":"1","key":"jvp210090r10","doi-asserted-by":"crossref","DOI":"10.1002\/mpr.1813","article-title":"Psychotic disorders hospitalizations associated with cannabis abuse or dependence.","volume":"29","author":"Gon\u00e7alves-Pinho","year":"2020","journal-title":"Int J Methods Psychiatr Res"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2782850\/jama_smith_2021_vp_210090_1629733294.2376.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T15:19:53Z","timestamp":1629818393000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2782850"}},"subtitle":["Reasons for Concern"],"short-title":[],"issued":{"date-parts":[[2021,8,24]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8,24]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2021.12481","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,24]]}}}